Clinical trials
Phase 1/2 Sarcoma, Ewing trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 4 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
| Completed | 11 |
| Unknown status | 5 |
| Terminated | 5 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Children's Oncology Group | 2 |
| M.D. Anderson Cancer Center | 2 |
| Milton S. Hershey Medical Center | 2 |
| Peking University People's Hospital | 2 |
| Shenzhen Geno-Immune Medical Institute | 2 |
| Ann & Robert H Lurie Children's Hospital of Chicago | 1 |
| Bambino Gesù Hospital and Research Institute | 1 |
| Bayer | 1 |
| Bristol-Myers Squibb | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sarcoma, Ewing | 40 |
| Sarcoma | 20 |
| Osteosarcoma | 17 |
| Rhabdomyosarcoma | 17 |
| Neuroblastoma | 13 |
| Wilms Tumor | 6 |
| Bone Neoplasms | 5 |
| Lymphoma | 5 |
| Neoplasms | 5 |
| Rhabdoid Tumor | 5 |
Trials
Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.